Markets
← Back to Stocks
PODD
INSULET CORP
Health Care · Health Care Equipment
$228.65
-0.91%
Vol: 0.0M
Araverus Market Read
Thursday, March 19, 2026
Insulet tumbles 2.99% after-hours on voluntary Omnipod 5 device correction impacting 1.5% of annual production despite strong financials.
PODD after-hours at $229.00, down 2.99% ($7.07) on voluntary device correction announced March 12 for certain Omnipod 5 Pod lots with internal tubing tears causing insulin leakage. Insulet reported 18 serious adverse events including hospitalization and DKA with zero deaths. Q4 revenue up 31.2% to $783.8M with 72.5% gross margin. Stock down 14.8% since February 18.
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$16.1B
P/E (TTM)65.7
Forward P/E28.3
Beta1.44
Div Yield—
Prev Close$230.75
RSI (14-Day)
32Neutral
0305070100
52-Week Range
$216.49$228.65$354.88
From High-35.6%
From Low+5.6%
Moving Averages
50d SMA
$254.60-10.2%
200d SMA
$297.58-23.2%
Price below 200d MA — bearish structure.
Returns
1W
-3.1%
1M
-11.4%
3M
-20.8%
6M
-29.0%
1Y
-12.2%
YTD
-19.2%
Volume
Today19K
20d Avg1.1M
Ratio0.02x